News Details

View all news

Veeco Reports Third Quarter 2022 Financial Results

November, 07, 2022

Third Quarter 2022 Highlights:

  • Revenues of $171.9 million, compared with $150.2 million in the same period last year
  • GAAP net income of $15.0 million, or $0.27 per diluted share, compared with $9.0 million, or $0.17 per diluted share in the same period last year
  • Non-GAAP net income of $26.0 million, or $0.45 per diluted share, compared with $20.5 million, or $0.40 per diluted share in the same period last year

PLAINVIEW, N.Y., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its third quarter ended September 30, 2022. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for certain items (“Non-GAAP”). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.

U.S. Dollars in millions, except per share data
             
GAAP Results   Q3 '22   Q3 '21
Revenue   $ 171.9   $ 150.2
Net income   $ 15.0   $ 9.0
Diluted earnings per share   $ 0.27   $ 0.17

 

             
Non-GAAP Results   Q3 '22   Q3 '21
Operating income   $ 28.4   $ 24.3
Net income   $ 26.0   $ 20.5
Diluted earnings per share   $ 0.45   $ 0.40

“With significant contributions from our laser annealing product line, as well as systems for advanced packaging and EUV mask blank production, we achieved another record revenue quarter in our semiconductor business which drove robust year-on-year revenue growth for the company,” commented Bill Miller, Veeco’s Chief Executive Officer. “Despite the challenging current macro environment, we continue to invest in executing our growth strategy, are well positioned with attractive technologies and we are optimistic about expanding our served available market.”

Guidance and Outlook

The following guidance is provided for Veeco’s fourth quarter 2022:

  • Revenue is expected in the range of $150 million to $170 million
  • GAAP diluted earnings per share are expected in the range of $0.05 to $0.23
  • Non-GAAP diluted earnings per share are expected in the range of $0.24 to $0.40

Conference Call Information

A conference call reviewing these results has been scheduled for today, November 7, 2022 starting at 5:00pm ET. To join the call, dial 1-866-580-3963 (toll free) or 1-786-697-3501 and use password VECOQ32022. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco's website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website that evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

About Veeco

Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our proven ion beam, laser annealing, lithography, MOCVD, and single wafer etch & clean technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

Forward-looking Statements

This press release contains “forward-looking statements”, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, as amended, that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements include, but are not limited to, those regarding anticipated growth and trends in our businesses and markets, industry outlooks and demand drivers, our investment and growth strategies, our development of new products and technologies, our business outlook for current and future periods, the impact of the COVID-19 pandemic, our ongoing transformation initiative and the effects thereof on our operations and financial results; and other statements that are not historical facts. These statements and their underlying assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from those expressed or implied by such statements include, without limitation: the level of demand for our products; global economic and industry conditions; the effects of regional or global health epidemics, including the effects of the COVID-19 pandemic on the Company’s operations and on those of our customers and suppliers; global trade issues, including the ongoing trade disputes between the U.S. and China, and changes in trade and export license policies; our dependency on third-party suppliers and outsourcing partners; the timing of customer orders; our ability to develop, deliver and support new products and technologies; our ability to expand our current markets, increase market share and develop new markets; the concentrated nature of our customer base; our ability to obtain and protect intellectual property rights in key technologies; our ability to achieve the objectives of operational and strategic initiatives and attract, motivate and retain key employees; the variability of results among products and end-markets, and our ability to accurately forecast future results, market conditions, and customer requirements; the impact of our indebtedness, including our convertible senior notes and our capped call transactions; and other risks and uncertainties described in our SEC filings on Forms 10-K, 10-Q and 8-K, and from time-to-time in our other SEC reports. All forward-looking statements speak only to management’s expectations, estimates, projections and assumptions as of the date of this press release or, in the case of any document referenced herein or incorporated by reference, the date of that document. The Company does not undertake any obligation to update or publicly revise any forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.

-financial tables attached-

Veeco Contacts:      
       
Investors: Anthony Bencivenga (516) 252-1438 abencivenga@veeco.com
Media: Kevin Long (516) 714-3978 klong@veeco.com 



Veeco Instruments Inc. and Subsidiaries

Condensed Consolidated Statements of Operations
(in thousands, except per share amounts)
(unaudited)

                           
    Three months ended September 30,   Nine months ended September 30,  
    2022     2021     2022     2021    
Net sales   $ 171,913     $ 150,246     $ 492,338     $ 430,305    
Cost of sales     101,962       87,077       292,109       252,055    
Gross profit     69,951       63,169       200,229       178,250    
Operating expenses, net:                          
Research and development     27,104       21,999       77,237       66,397    
Selling, general, and administrative     22,144       21,603       67,987       63,325    
Amortization of intangible assets     2,505       2,976       7,514       9,305    
Other operating expense (income), net     634       175       587       138    
Total operating expenses, net     52,387       46,753       153,325       139,165    
Operating income     17,564       16,416       46,904       39,085    
Interest expense, net     (2,315 )     (7,012 )     (7,753 )     (20,221 )  
Income before income taxes     15,249       9,404       39,151       18,864    
Income tax expense (benefit)     208       411       1,125       1,029    
Net income   $ 15,041     $ 8,993     $ 38,026     $ 17,835    
                           
Income per common share:                          
Basic   $ 0.30     $ 0.18     $ 0.76     $ 0.36    
Diluted   $ 0.27     $ 0.17     $ 0.70     $ 0.33    
                           
Weighted average number of shares:                          
Basic     49,887       49,021       49,831       48,968    
Diluted     65,151       53,849       65,090       53,606    



Veeco Instruments Inc. and Subsidiaries

Condensed Consolidated Balance Sheets
(in thousands)

             
    September 30,   December 31,
    2022   2021
    (unaudited)      
Assets            
Current assets:            
Cash and cash equivalents   $ 169,111   $ 119,747
Restricted cash     557     725
Short-term investments     101,862     104,181
Accounts receivable, net     142,985     109,609
Contract assets     29,865     18,293
Inventories     187,737     170,858
Prepaid expenses and other current assets     17,586     25,974
Total current assets     649,703     549,387
Property, plant and equipment, net     108,416     99,743
Operating lease right-of-use assets     25,119     28,813
Intangible assets, net     26,391     33,905
Goodwill     181,943     181,943
Deferred income taxes     1,639     1,639
Other assets     3,406     3,546
Total assets   $ 996,617   $ 898,976
             
Liabilities and stockholders’ equity            
Current liabilities:            
Accounts payable   $ 51,129   $ 44,456
Accrued expenses and other current liabilities     65,062     79,752
Customer deposits and deferred revenue     122,285     63,136
Income taxes payable     1,565     1,860
Current portion of long-term debt     20,144    
Total current liabilities     260,185     189,204
Deferred income taxes     4,748     4,792
Long-term debt     254,272     229,438
Long-term operating lease liabilities     31,266     32,834
Other liabilities     5,031     5,080
Total liabilities     555,502     461,348
             
Total stockholders’ equity     441,115     437,628
Total liabilities and stockholders’ equity   $ 996,617   $ 898,976

Note on Reconciliation Tables

The below tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

Reconciliation of GAAP to Non-GAAP Financial Data (Q3 2022)
(in thousands)
(unaudited)

                           
          Non-GAAP Adjustments        
          Share-Based                
Three months ended September 30, 2022   GAAP   Compensation   Amortization   Other   Non-GAAP  
Net sales   $ 171,913               $ 171,913  
Gross profit     69,951   1,195         1,102       72,248  
Gross margin     40.7 %               42.0 %
Operating expenses     52,387   (5,015 )   (2,505 )   (981 )     43,886  
Operating income     17,564   6,210     2,505     2,083   ^   28,362  
Net income     15,041   6,210     2,505     2,252   ^   26,008  

 

______________________
^   - See table below for additional details.


Other Non-GAAP Adjustments (Q3 2022)

(in thousands)
(unaudited)

     
Three months ended September 30, 2022    
Transition expenses related to San Jose expansion project $ 1,936  
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting   147  
Subtotal   2,083  
Non-cash interest expense   242  
Non-GAAP tax adjustment *   (73 )
Total Other $ 2,252  

 

______________________

*   - The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.


Net Income per Common Share (Q3 2022)

(in thousands, except per share amounts)
(unaudited)

             
    Three months ended September 30, 2022
    GAAP   Non-GAAP
Numerator:            
Net income   $ 15,041   $ 26,008
Interest expense associated with convertible notes     2,549     2,467
Net income available to common shareholders   $ 17,590   $ 28,475
             
Denominator:            
Basic weighted average shares outstanding     49,887     49,887
Effect of potentially dilutive share-based awards     801     801
Dilutive effect of 2023 Convertible Senior Notes         504
Dilutive effect of 2025 Convertible Senior Notes     5,521     5,521
Dilutive effect of 2027 Convertible Senior Notes(1)     8,942     6,771
Diluted weighted average shares outstanding     65,151     63,484
             
Net income per common share:            
Basic   $ 0.30   $ 0.52
Diluted   $ 0.27   $ 0.45

 

______________________
(1) - The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, an effective conversion price of $18.46 is used when determining incremental shares to add to the dilutive share count. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, an effective conversion price of $13.98 is used when determining incremental shares to add to the dilutive share count.


Reconciliation of GAAP to Non-GAAP Financial Data (Q3 2021)

(in thousands, except per share amounts)
(unaudited)

                           
          Non-GAAP Adjustments        
          Share-based              
Three months ended September 30, 2021     GAAP   Compensation   Amortization   Other   Non-GAAP  
Net sales   $ 150,246               $ 150,246  
Gross profit     63,169   620         150       63,939  
Gross margin     42.0 %               42.6 %
Operating expenses     46,753   (3,510 )   (2,976 )   (637 )     39,630  
Operating income     16,416   4,130     2,976     787   ^   24,309  
Net income     8,993   4,130     2,976     4,375   ^   20,474  
                           
Income per common share:                          
Basic   $ 0.18               $ 0.42  
Diluted     0.17                 0.40  
Weighted average number of shares:                          
Basic     49,021                 49,021  
Diluted(1)     53,849                 51,679  

 

______________________
^ - See table below for additional details.

(1) - The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, no incremental shares are added to the dilutive share count in periods in which the average stock price per share is below $18.46. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, incremental shares are added to the dilutive share count in periods in which the average stock price per share is above $13.98, and the Company is in a net income position. The average stock price for the three months ended September 30, 2021 was $22.24, and therefore 1.2 million shares were included in the non-GAAP diluted share count, and 3.3 million shares were included in the GAAP diluted share count related to the 2027 Notes.


Other Non-GAAP Adjustments (Q3 2021)

(in thousands)
(unaudited)

     
Three months ended September 30, 2021    
Transition expenses related to San Jose expansion project $ 705  
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting   82  
Subtotal   787  
Non-cash interest expense   3,663  
Non-GAAP tax adjustment *   (75 )
Total Other $ 4,375  

 

______________________
*   - The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.


Reconciliation of GAAP Net Income to Non-GAAP Operating Income (Q3 2022 and 2021)

(in thousands)
(unaudited)

             
    Three months ended   Three months ended
    September 30, 2022   September 30, 2021
GAAP Net income   $ 15,041   $ 8,993
Share-based compensation     6,210     4,130
Amortization     2,505     2,976
Transition expenses related to San Jose expansion project     1,936     705
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting     147     82
Interest (income) expense, net     2,315     7,012
Income tax expense (benefit)     208     411
Non-GAAP Operating income   $ 28,362   $ 24,309


Reconciliation of GAAP to Non-GAAP Financial Data (Q4 2022)

(in millions, except per share amounts)
(unaudited)

                                               
                    Non-GAAP Adjustments                  
Guidance for the three months ending                   Share-based                          
December 31, 2022   GAAP   Compensation   Amortization   Other   Non-GAAP  
Net sales   $ 150     -   $ 170                 $ 150     -   $ 170    
Gross profit     56     -     68     1         1       58     -     70    
Gross margin     37 %   -     40 %                 39 %   -     41 %  
Operating expenses     51     -     53     (5 )   (3 )   (1 )     43     -     45    
Operating income     5     -     15     6     3     1       15     -     25    
Net income   $ 2     -   $ 12     6     3     2     $ 13     -   $ 23    
                                               
Income per diluted common share   $ 0.05     -   $ 0.23                 $ 0.24     -   $ 0.40    


Income per Diluted Common Share (Q4 2022)

(in millions, except per share amounts)
(unaudited)

                                 
Guidance for the three months ending December 31, 2022   GAAP   Non-GAAP
Numerator:                                
Net income   $ 2   -   $ 12   $ 13   -   $ 23
Interest expense associated with convertible notes             3     2         2
Net income available to common shareholders   $ 2   -   $ 15   $ 15   -   $ 25
                                 
Denominator:                                
Basic weighted average shares outstanding     50         50     50         50
Effect of potentially dilutive share-based awards     1         1     1         1
Dilutive effect of 2023 Convertible Senior Notes                        
Dilutive effect of 2025 Convertible Senior Notes             6     6         6
Dilutive effect of 2027 Convertible Senior Notes(1)             9     7         7
Diluted weighted average shares outstanding     51         66     64         64
                                 
Net income per common share:                                
Income per diluted common share   $ 0.05   -   $ 0.23   $ 0.24   -   $ 0.40

______________________
(1) - The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, an effective conversion price of $18.46 is used when determining incremental shares to add to the dilutive share count. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, an effective conversion price of $13.98 is used when determining incremental shares to add to the dilutive share count.


Reconciliation of GAAP Net Income to Non-GAAP Operating Income (Q4 2022)

(in millions)
(unaudited)

                 
Guidance for the three months ending December 31, 2022                
GAAP Net income   $ 2   -   $ 12
Share-based compensation     6   -     6
Amortization     3   -     3
Interest expense, net     2   -     2
Other     2   -     2
Non-GAAP Operating income   $ 15   -   $ 25

Note: Amounts may not calculate precisely due to rounding.

 


Primary Logo

Source: Veeco Instruments Inc.

Multimedia Files:

Categories: Press Releases
View all news